09:23 AM EDT, 06/05/2026 (MT Newswires) -- Healthcare stocks were rising premarket Friday, with the State Street Health Care Select Sector SPDR ETF ( XLV ) advancing by 0.7% and the iShares Biotechnology ETF (IBB) 0.3% higher.

Amneal Pharmaceuticals ( AMRX ) stock was up more than 2% after the company said interim results from its phase 4 study of Crexont to treat Parkinson's disease demonstrated substantial clinical benefit after patients switched to the drug from Rytary.

BioCardia ( BCDA ) has received confirmation from the US Food and Drug Administration that its ongoing heart failure trial may support a premarket approval of the CardiAMP Cell Therapy System for the treatment of ischemic heart failure with reduced ejection fraction, the company said. Shares of BioCardia ( BCDA ) were up more than 33% pre-bell.